Jacobsson L, von Knorring L, Mattsson B, Mjörndal T, Oreland L, Perris C, Rapp W, Edenius B, Kettner B, Magnusson K E, Villemoes P
Int Pharmacopsychiatry. 1976;11(4):206-14.
Plasma levels of penfluridol and thiothixene were studied after 4 weeks treatment in a double-blind controlled trial of 47 patients suffering from chronic schizophrenic syndromes. There was found a tenfold variation in plasma levels for penfluridol, and about a twentyfold variation for thiothixene. For penfluridol, a significant correlation between dosage and plasma level and also between dosage and changes in psychopathology as regards factor 5 in the Märtens & Jonsson S scale which comprises the items most characteristic of a schizophrenic syndrome, was found. For thiothixene, a significant correlation between plasma levels and changes in factor 5 was found. A gas-chromatographic method for penfluridol is also described.
在一项针对47例慢性精神分裂症综合征患者的双盲对照试验中,研究了治疗4周后五氟利多和硫利达嗪的血浆水平。发现五氟利多的血浆水平有10倍的差异,硫利达嗪约有20倍的差异。对于五氟利多,在剂量与血浆水平之间以及剂量与马滕斯和琼森S量表中因子5的精神病理学变化之间发现了显著相关性,该量表包含精神分裂症综合征最具特征性的项目。对于硫利达嗪,发现血浆水平与因子5的变化之间存在显著相关性。还描述了一种测定五氟利多的气相色谱法。